Atrophy of S6K1-/- skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control

Nature Cell Biology

Volumn 7, Issue 3, 2005, Pages 286-294

  Ohanna, Mickaël ^a   Sobering, Andrew K ^a   Lapointe, Thomas ^a   Lorenzo, Lazaro ^a   Praud, Christophe ^a   Petroulakis, Emmanuel ^b   Sonenberg, Nahum ^b   Kelly, Paul A ^a   Sotiropoulos, Athanassia ^a   Pende, Mario ^a  

^a INSERM   (France)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; RAPAMYCIN; S6 KINASE; SOMATOMEDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; CELL SIZE; CONTROLLED STUDY; CYTOPLASM; GENE ACTIVATION; GENE DELETION; GROWTH DISORDER; HYPERTROPHY; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE TUMOR; MYOBLAST; MYOTUBE; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SKELETAL MUSCLE;

ANIMALS; ATROPHY; BODY WEIGHT; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; GENE DELETION; GENETIC VECTORS; GENOTYPE; GREEN FLUORESCENT PROTEINS; HOMOZYGOTE; HUMANS; IMMUNOBLOTTING; LAMININ; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; MUSCLES; PLASMIDS; PROTEIN BINDING; PROTEIN KINASES; PROTEOGLYCANS; RETROVIRIDAE; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SOMATOMEDINS; TIME FACTORS; TRANSFECTION;

ANIMALIA; MAMMALIA;

EID: 20044392290     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1231     Document Type: Article

References (25)

1. Rommel, C. et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nature Cell Biol. 3, 1009-1013 (2001).
2. Bodine, S. C. et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nature Cell Biol. 3, 1014-1019 (2001).
3. Pallafacchina, G., Calabria, E., Serrano, A. L., Kalhovde, J. M. & Schiaffino, S. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc. Natl. Acad. Sci. USA 99, 9213-9218 (2002).
4. Erbay, E., Park, I. H., Nuzzi, P. D., Schoenherr, C. J. & Chen, J. IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. J. Cell Biol. 163, 931-936 (2003).
5. Sandri, M. et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399-412 (2004).
6. Stitt, T. N. et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 14, 395-403 (2004).
7. Glass, D. J. Molecular mechanisms modulating muscle mass. Trends Mol. Med. 9, 344-350 (2003).
8. Abraham, R. T. Identification of TOR signaling complexes: more TORC for the cell growth engine. Cell 111, 9-12 (2002).
9. Manning, B. D. & Cantley, L. C. Rheb fills a GAP between TSC and TOR. Trends Biochem. Sci. 28, 573-576 (2003).
10. Coolican, S. A., Samuel, D. S., Ewton, D. Z., McWade, F. J. & Florini, J. R. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272, 6653-6662 (1997).
11. Huang, S. et al. Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). Mol. Cell 11, 1491-1501 (2003).
12. Montagne, J. et al. Drosophila S6 kinase: a regulator of cell size. Science 285, 2126-2129 (1999).
13. Zhang, H., Stallock, J. P., Ng, J. C., Reinhard, C. & Neufeld, T. P. Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 14, 2712-2724 (2000).
14. Miron, M. et al. The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila. Nature Cell Biol. 3, 596-601 (2001).
15. Fingar, D. C., Salama, S., Tsou, C., Harlow, E. & Blenis, J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16, 1472-1487 (2002).
16. Fingar, D. C. et al. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol. Cell. Biol. 24, 200-216 (2004).
17. -/-) Mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol. Cell. Biol. 24, 3112-3124 (2004).
18. Pende, M. et al. Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature 408, 994-997 (2000).
19. Gingras, A. C. et al. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 15, 2852-2864 (2001).
20. Whiteman, E. L., Cho, H. & Birnbaum, M. J. Role of Akt/protein kinase B in metabolism. Trends Endocrinol. Metab 13, 444-451 (2002).
21. Lorberg, A. & Hall, M. N. TOR: the first 10 years. Curr. Top. Microbiol. Immunol. 279, 1-18 (2004).
22. Conlon, I. & Raff, M. Differences in the way a mammalian cell and yeast cells coordinate cell growth and cell-cycle progression. J. Biol. 2, 7 (2003).
23. Dolznig, H., Grebien, F., Sauer, T., Beug, H. & Mullner, E. W. Evidence for a size-sensing mechanism in animal cells. Nature Cell Biol. 6, 899-905 (2004).
24. Shima, H. et al. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 17, 6649-6659 (1998).
25. Pinset, C. & Montarras, D. in Cell Biology, a Laboratory Handbook (ed. Celis, J.) 226-232 (Academic, New York, 1998).